ClinicalTrials.gg
Sign In

Neurocysticercosis clinical trials

The registry lists 21 studies for Neurocysticercosis across 6 countries. 5 are recruiting or about to start. 20 of them are mainly about Neurocysticercosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Neurocysticercosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
11
Not yet recruiting
4
Terminated
3
Withdrawn
2
Recruiting
1

Phase

Phase 3
7
Phase 1
4
Phase 2
4
Phase 4
1

Where

United States
5
Peru
5
Tanzania
2
Zambia
1
India
1
Ecuador
1

Who runs them

Universidad Peruana Cayetano Heredia (4) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Technical University of Munich (3) · Oregon Health and Science University (2) · All India Institute of Medical Sciences, New Delhi (2) · National Institute of Mental Health (NIMH) (2) · R-Evolution Worldwide S.r.l. Impresa Sociale (1) · Cephas Health Research Initiative Inc, Ibadan, Nigeria (1)

What is being tested here

Drugs under test in Neurocysticercosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Albendazole145
Praziquantel123
Oxfendazole002
Dexamethasone022
Pbr-28001
Omeprazole011
Niclosamide001
Acetazolamide011

Coming up

1phase 3 study under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 1 Neurocysticercosis studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
101 (100%)1 (100%)
181 (100%)1 (100%)
301 (100%)1 (100%)
401 (100%)1 (100%)
501 (100%)1 (100%)
651 (100%)1 (100%)
751 (100%)1 (100%)
851 (100%)1 (100%)

Across all 21 studies, recruiting or not: 52% stop at 75 or younger and 43% at 65; 48% take children; 0% are for women only and 0% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. search them.